Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Proteome Sciences plc    PRM   GB0003104196

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
04/16/2014 04/17/2014 04/22/2014 04/23/2014 04/24/2014 Date
36.75(c) 37(c) 35.5(c) 36.25(c) 35.5 Last
328 831 12 094 102 302 67 203 229 423 Volume
-0.68% +0.68% -4.05% +2.11% -2.07% Change
More quotes
Company
Proteome Sciences Plc is a protein biomarker discovery service company. It offers sensitivity, proprietary technologies for protein and peptide biomarker discovery, validation and assay development. Its PS biomarker services uses isobaric and isotopic Tandem Mass Tag workflows developed on the... 
Surperformance© rating of Proteome Sciences plc
Trading Rating : Investor Rating :
More about the company
Chart PROTEOME SCIENCES PLC
Duration : Period :
Proteome Sciences plc Technical Analysis Chart | PRM | GB0003104196 | 4-Traders
Full-screen chart
Financials ( GBP)
Sales 2013 2,01 M
EBIT 2013 -3,55 M
Net income 2013 -3,16 M
Debt 2013 2,86 M
Yield 2013 -
Sales 2014 5,90 M
EBIT 2014 -0,49 M
Net income 2014 0,28 M
Debt 2014 0,72 M
Yield 2014 -
PER 2013 -
PER 2014 362,50
EV / Sales 2013 40,0x
EV / Sales 2014 13,3x
Capitalization 77,6 M
More Financials
Latest news on PROTEOME SCIENCES PLC
04/08 PROTEOME SCIENCES : SysQuant® -Pancreatic Cancer Study Poster being presented at..
03/31 PROTEOME SCIENCES : SysQuant® -Pancreatic Cancer Study in PLOS ONE
03/27 PROTEOME SCIENCES : announces publication of SysQuant Pancreatic Cancer Study in..
03/27 PROTEOME SCIENCES : SysQuant® - Pancreatic Cancer Study in PLOS ONE
03/24 PROTEOME SCIENCES : Industry-Academic Collaboration Targets Major Proteomics Qua..
03/03 PROTEOME SCIENCES PLC : Change of Directorship
01/06 PROTEOME SCIENCES PLC : Publication Release: "Developing novel blood-based bioma..
2013 PROTEOME SCIENCES PLC : Novel Patient Stratification Biomarkers for Liver Cancer
2013 PROTEOME SCIENCES PLC : Proteome Sciences appoints Director of Personalized Medi..
2013 PROTEOME SCIENCES PLC : Proteome Sciences appoints Director of Personalised Medi..
2013 PROTEOME SCIENCES PLC : Proteome Sciences Releases Block Admission Return
2013 PROTEOME SCIENCES PLC : New Product for Alzheimer's Disease Research
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
Proteome Sciences plc : Income Statement Evolution
More Financials
EPS Revisions
Proteome Sciences plc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF